Incannex Healthcare Inc.
Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.
IXHL | US
Overview
Corporate Details
- ISIN(s):
- US45333L1061
- LEI:
- Country:
- United States of America
- Address:
- 8 CENTURY CIRCUIT, 0 NORWEST NSW
- Website:
- http://www.incannex.com
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company that develops innovative combination therapeutics for chronic conditions with unmet medical needs. The company's science-led approach focuses on creating novel oral treatments, including cannabinoid and psychedelic-based medicines, that target underlying biological pathways. Its development pipeline is focused on addressing obstructive sleep apnea (OSA), rheumatoid arthritis (RA), and generalized anxiety disorder (GAD). A key drug candidate, IHL-42X for OSA, is undergoing a pivotal Phase 2/3 clinical trial, which commenced dosing in May 2024.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Incannex Healthcare Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Incannex Healthcare Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Incannex Healthcare Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
